DNA Spotting Buffer and Protein Spotting Buffers

CapitalBio DNA Spotting Buffer is an optimized spotting solution system for DNA and oligonucleotide microarray applications, including modified DNA and oligonucleotides. The spotting solution consists of advanced formula for stabilizing nucleic acids and minimizing evaporation, having optimal viscidity and surface tension for contact spotting on various coated glass substrates. The buffer increases DNA deposition, spot precision and uniformity. The buffer will produce the best results when spotting on CapitalBio microarray substrates. 

CapitalBio Protein Spotting Buffers are optimized spotting solutions for antigen and antibody microarray applications. The spotting buffers consist of proprietary ingredients for stabilizing protein and minimizing evaporation, featuring optimal viscidity and surface tension for contact spotting on various coated glass substrates. The buffers also increase protein immobilization, spot morphology and uniformity. Optimal results will be obtained when used with CapitalBio microarray substrates. CapitalBio OPPolymerSlide G is recommended to be used together with the Protein Spotting Buffer A. CapitalBio OPEpoxySlide is recommended to be used together with the Protein Spotting Buffer B.

KEY FEATURES

• Optimal for microarray spotting for various cDNA, oligonucleotide and protein samples;
• Improved spot morphology and hybridization signal intensity;
• Able to stabilize spotted DNA and protein samples for prolonged storage;
• Easy storage; Shelf-life as long as 18 months.

APPLICATIONS

• DNA and protein microarray spotting on various substrates, by contact or non-contact methods
• Microarray gene expression profile experiment quality control
• Evaluation of microarray sensitivity, data linear range and data saturation

Company Info:

Headquartered in Beijing, China, CapitalBio is a leading life science Company that develops and commercializes total health-care solutions including a broad range of innovative biochip-related products for genomic, proteomic and cellomic research, bio-safety testing, clinical applications and to address wider human health needs. CapitalBio warmly encourages discussion of new business, marketing and production opportunities, etc. Both through innovation and a commitment to rapid product development, 

CapitalBio is seeking to reduce the cost of products, to benefit our customers.

For further information and detailed budget, send us an email to technicalsupport@biotools.eu >>

USER MANUALS

• Sppotting-Buffers

References

Patterson et al (2006) Nature Biotech- nology 24:1140-1150 and Shi et al (2006) Nature Biotechnology, 24:1151-1161.